96
Participants
Start Date
December 31, 2007
Primary Completion Date
September 30, 2009
Study Completion Date
March 31, 2010
Placebo
Oral solution qd or bid for 6 weeks
Risperidone high dose
Risperidone oral solution 1.25 mg (if \<45 kg) or 1.75 mg (if \>=45 kg) qd or bid for 6 weeks
Risperidone low dose
Risperidone oral solution 0.125 mg (if \<45 kg) or 0.175 mg (if \>=45 kg) qd or bid for 6 weeks
Dothan
Phoenix
Sacramento
Santa Ana
Boca Raton
Miami
Smyrna
Hoffman Estates
Naperville
Lake Charles
Manhasset
New York
Staten Island
The Bronx
Columbus
Oklahoma City
Philadelphia
Houston
Fairfax
Portsmouth
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY